DexCare Stock

www.dexcare.com/Enterprise Software / Business OperationsFounded: 2016Funding to Date: $146MM

DexCare, founded in 2020, is a digital health company aiming to optimize health system capacity through data-driven solutions. The company's mission is to create seamless, personalized healthcare experiences by intelligently allocating health system resources. DexCare's platform seeks to integrate with healthcare providers' existing systems to manage patient demand, service line growth, and care delivery. The company is based in Seattle, Washington.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for DexCare, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Private Market Pricing DetailsValuation & Financings

DexCare Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

DexCare Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
06/23/2023 Series C-1 $15MM $xx.xx $430.46MM Iconiq Growth, Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, SpringRock Ventures
Price per Share
$xx.xx
Shares Outstanding
8,154,922
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Iconiq Growth, Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, SpringRock Ventures
06/23/2023 Series C $60MM $xx.xx $430.46MM Iconiq Growth, Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, SpringRock Ventures
Price per Share
$xx.xx
Shares Outstanding
26,095,806
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Iconiq Growth, Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, SpringRock Ventures
01/13/2022 Series B $50MM $xx.xx $211.09MM Transformation Capital, Define Ventures, Frist Cressey Ventures, Kaiser Permanente Ventures, SpringRock Ventures, Providence Ventures
Price per Share
$xx.xx
Shares Outstanding
34,040,231
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Transformation Capital, Define Ventures, Frist Cressey Ventures, Kaiser Permanente Ventures, SpringRock Ventures, Providence Ventures
03/22/2021 Series A $21MM $xx.xx $52.5MM Define Ventures, Frist Cressey Ventures, Kaiser Permanente Ventures, SpringRock Ventures, Providence Ventures
Price per Share
$xx.xx
Shares Outstanding
37,815,348
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Define Ventures, Frist Cressey Ventures, Kaiser Permanente Ventures, SpringRock Ventures, Providence Ventures

DexCare investors also invested in these private companies

Leadership & Board

Leadership

Derek Streat
Co-Founder & Chief Executive Officer
Rick Pittenger
Chief Technology Officer
Julia Millard
Chief Customer Experience Officer
Jamie Gier
Chief Marketing Officer
Robin Borg
Chief People Officer
Catherine Stach
Chief Product Officer
Sean O'Connor
Co-Founder & Chief Commercial Officer

Board

David Kereiakes
Providence Ventures
Lynne O'Keefe
Define Ventures
Todd Cozzens Ph.D
Transformation Capital

DexCare stock FAQs

plusminus

Can you buy DexCare stock?

As DexCare is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like DexCare, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy DexCare stock?

To invest in a private company like DexCare through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell DexCare stock?

Yes, you may sell the DexCare stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell DexCare stock?

If you hold private company shares of DexCare – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your DexCare on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is DexCare a public company?

No, DexCare is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is DexCare’s stock price?

DexCare is a privately held company and therefore does not have a public stock price. However, you may access DexCare private market stock price with Forge Data.
plusminus

What is DexCare’s stock ticker symbol?

DexCare does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

DexCare’s news and media highlights

DexCare, Inc., the leading patient demand and care access platform, has named Robin Borg, SPHR, as chief people officer (CPO). As CPO, Borg strengthens DexCare’s recruiting and talent development process, and will further unify teams across locations. With more than 30 years of experience in human resources, Borg plays an essential role to ensure DexCare attracts and retains top-notch talent to support the company’s continued growth.
DexCare, Inc., the leading patient demand and care access platform, today announced the close of its $75 million Series C funding round led by ICONIQ Growth. The funding will advance DexCare’s platform, which extends limited health-system capacity to serve patients faster and to precisely manage the supply and demand of digital-care access.
DexCare, Inc., the leading patient demand and care access platform, today announced its industry impact and business growth results, commemorating its two-year anniversary following its spinout from Providence.
Updated on: Nov 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.